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1. Introduction 
The genus Chlamydia includes a unique group of aerobic Gram-negative obligate 
intracellular parasitic bacteria of eubacterial origin which cause numerous infectious 
diseases in humans and animals. Despite some inherited genomic and phenotypic variations 
there is one distinctive feature of all chlamydial pathogens, most cases of chlamydial 
infection are initiated, developed and resolved within the epithelium of the bronchoalveolar 
system, urogenital system or conjunctivae. Generally, mucosal epithelial tissue and its 
residing/migrating cellular constituents serve as the primary focus of microbial insult as 
well as a preferential cell population supporting chlamydial growth. Despite strict tissue 
tropism and the unique capability of chlamydial pathogens to infect, propagate and finalize 
their life cycle in mucosal epithelial cells, there is a growing body of evidence that 
chlamydial species can grow in other cell types thereby invading multiple tissues and 
organs far beyond the primary locus of infection. The purpose of this chapter is to analyze 
some novel observations revealing the ability of chlamydial species to grow in hepatic cells 
along with reports on liver involvement in the pathogenesis of chlamydial infection. This 
has been done within the modern framework of understanding the molecular biology of 
chlamydial species and their growth requirements in host cells .  
All chlamydial strains have a similar genetic background and share major cutoff points in 
their developmental cycle, phenotypic characteristics and mechanisms of infectivity . The 
separation of genus Chlamydia into two genera – Chlamydia and Chlamydophila introduced in 
1999 (Everett et al  1999) reflects some variations in the clustering of the 16S rRNA gene and 
was disputed soon after proposal/introduction (Schachter et al., 2001) . It has been opposed 
recently by new data on complete chlamydial genome sequencing (Stephens et al., 2001; 
Myers et al., 2009). Although there are several exceptions, all chlamydial species are >97% 
similar by 16S rRNA gene sequence comparison which undermines taxonomic separation of 
the genus (Stephens et al., 2001) . With this proviso a reunited genus Chlamydia  includes 3 
clinically relevant obligate pathogens: C. trachomatis, C. pneumoniae and C. psittaci.  
2. Chlamydia as a pathogen 
The first member of genus Chlamydia was identified and reported by Ludwig Halberstaedter 
and Stanislaus von Prowazec (Halberstaedter & von Prowazec, 1907) during an expedition 
to the island of Java when they reproduced conjunctival lesions in orangutans by 






name for the new pathogen, they pointed out that the etiologic agent identified 
microscopically in the conjunctiva of the trachoma patients had nothing to do with the 
kingdom of bacteria and had to be distinguished equally from the protozoan organisms . 
Instead, vonProwazec introduced a new taxon “Chlamydozoa” to include the newly 
discovered pathogen under investigation (von Prowazec, 1907).  
Another pathogen belonging to the genus Chlamydia – Chlamydia psittaci had been initially 
shown to infect birds and can be transmitted to humans via direct contact causing 
psittacosis or parrot fever (Verminnen et al., 2008). The first cases of the human disease 
were reported in 1893 in Paris, France (Morange, 1895). However, detailed insight into the 
microbiology of Chlamydia psittaci was gained only after the introduction of cell culture 
technique and a large epidemic of psittacosis in the USA and Europe in 1930 (Vanrompay 
et al., 1995). 
Extensive trachoma research paved the way for the discovery of another member of genus 
Chlamydia. An atypical strain designated as TW-183 was isolated in 1965 from the eye of a 
child participating in a vaccine study led by Prof J. T. Grayston in Taiwan . However, it was 
not until 1985 that Grayston and collaborators accumulated multiple pieces of evidence to 
show that the Taiwanese isolate is linked to respiratory infections in adults and represents a 
new member of genus Chlamydia named Chlamydia pneumoniae (Saikku et al., 1985 ).  
From 1935 all chlamydial species were categorized as viruses since they could not 
synthesize ATP, did not grow in media and required a eukaryotic cell for propagation 
(Fields & Barnes, 1992). However, in 1963 the presence of the cell wall and its major 
chemical component - muramic acid was confirmed in several chlamydial strains (Perkinsh 
& Allsona, 1963; Garrett et al., 1974). This fact along with identification of ribosomes,   DNA 
and RNA structures revealed that all chlamydial species belong to the kingdom of bacteria 
(Moulder, 1982) .  
Although the infections caused by chlamydial pathogens are mostly asymptomatic, 
exposure to chlamydial pathogens worldwide is remarkably high. About 50-80% of the 
human population has detectable antibodies to C. pneumoniae, while 10-20% of adults show 
seropositivity to C. trachomatis (den Hartog et al., 2005; Asquith et al., 2011). Antibody 
specific to C. psittaci is found in a much smaller human population (0.1-3.0 %). However, the 
real infection rate might be seriously underestimated (Fenga et al., 2007).  
The incubation period for Chlamydia-induced infections is generally believed to vary, 
depending on the strain, from several days (C. trachomatis) to month and years (C. 
pneumoniae). Despite of extreme fluctuations in the time span of chlamydial disease, chronic 
course of infection and persistency in chlamydial biovar colonization is an ultimate feature 
of chlamydiosis (den Hartog et al., 2005; Asquith et al., 2011; Fenga et al., 2007).  
There is a remarkable variety of human disease attributable to the chlamydial pathogens. 
The spectrum of human disease is closely related to the subdivision of chlamydial 
pathogens into biological variants (biovars) and serological subtypes (serovars).  
C. trachomatis is represented by two biovars relevant to human pathology: the trachoma and 
lymphogranuloma venereum (LGV). Serovariants belonging to both C. trachomatis biovars 
differ in major outer membrane protein (MOMP) antigenicity and are known to cause 
various diseases: trachoma, sexually transmitted urogenital disease, some forms of arthritis, 
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and neonatal inclusion conjunctivitis and pneumonia (Carlson et al., 2004). The existence of 
different chlamydial “pathotypes” is attributed to small genomic differences (Miyairi et al., 
2006). Although the original classification includes 15 MOMP serovars of C. trachomatis, 
there are currently > 20 genovars and serovariants of the pathogen (Byrne, 2010). Their 
propagation is limited primarily to epithelial cells of mucous membranes . In contrast, it is 
believed that LGV serovars are more invasive due to their ability to invade the lymphatic 
system (Martin-Iquacel et al., 2010) .  
There are three distinct C. pneumoniae biovars: human biovar TWAR, equine biovar and 
koala biovar. All human isolates representing the TWAR group are almost 
indistinguishable from each other with 0.1% variation in 16S rRNA and 0.4% difference in 
the ompA gene (Kutlin et al., 2007). C. pneumoniae is a proven causative agent of acute and 
chronic respiratory infections (bronchitis, sinusitis, pneumonia etc) and possibly some 
other diseases. However, unequivocal proof of direct causal relationship between 
persistent C. pneumoniae infection and these internal diseases (atherosclerosis, multiple 
sclerosis, bronchial asthma and stroke) has not yet been presented (Burillo et al., 2010; 
Cochrane et al., 2005).  
Despite the obvious possibility of zoonotic transmission and identification of animal strains 
in humans (Dickx et al., 2010), the clinical manifestations of  C. psittaci infection  do not seem 
to reflect  serovar specificity. All eight serovars of C. psittaci have similar virulence, tissue 
tropism and highly conserved 16S rRNA (Grinblat-Huse et al., 2011; Fraeyman et al., 2010). 
Infection in birds and animals is often manifested by conjunctivitis and respiratory disease 
followed by septicemia and multi-organ failure in the most severe cases (Harkinezhad et al., 
2009). In humans, zoonotic psittacosis is most commonly represented by flu-like symptoms, 
fever and pneumonia (Beeckman & Vanrompay, 2009).  
3. Life cycle 
Chlamydiae are aerobic non-motile pear-shaped bacteria with a circularly arranged genome 
typically containing one plasmid. Chlamydia has a unique and dual faceted life cycle 
involving a switch between two naturally occurring biological forms: a large (~1.0 µM) 
intracellular, metabolically active and self-reproducing reticulate body (RB) and an 
extracellular, metabolically dormant, infectious elementary body (EB) of smaller (~0.3 µM) 
size (Kariagina et al., 2009) .  
Internalization of the chlamydial EB into eukaryotic cells is the first step of the chlamydial 
infectious cycle. Several mechanisms are implemented for chlamydial attachment/entry into 
phagocytic and non-phagocytic cells . Generally, receptor-mediated endocytosis in clathrin-
coated pits, pinocytosis in non-clathrin-coated pits and phagocytosis are among them 
(Puolakkainen et al., 2005). However, RNA interference experiments (Hybiske & Stephens, 
2007) have emphasized the predominant role of the clathrin-mediated pathway whereas 
caveolae, phagocytosis and macropinocytosis are less relevant, at least for C. trachomatis 
entry into non-phagocytic cells. Ligand-receptor interactions seem to be essential for 
chlamydial internalization, since attachment dynamics often display a saturation pattern 
(Hackstadt et al., 1985) . There are a number of chemical ligands on the chlamydial surface 
promoting attachment to eukaryotic cell membranes. Among them are heparan sulfate, 
major outer membrane protein, glycosaminoglycans, heat shock protein 70, and OmcB 






Although identification of a single eukaryotic receptor responsible for chlamydial 
attachment and subsequent entry into host cells remains elusive, a number of membrane 
receptors are implemented in the internalization of chlamydial species. These include 
insulin-like growth factor 2, epithelial membrane protein 2, polymorphic membrane 
proteins (PMP), mannose 6-phosphate receptor, estrogen receptor complex, platelet-derived 
growth factor receptor and possibly LDL-receptor (Dautry-Varsat et al., 2004; Puolakkainen 
et al.,2005; Abromatis & Stephens, 2009; Bashmakov et al., 2010) . It is obvious that the 
variety of receptors and other polyvalent interactions between chlamydial pathogens and 
host cell membrane implemented for chlamydial entry reflect some differences in the mode 
of exposure to the pathogen, presence or absence of centrifugation force during inoculation, 
as well as electrolyte composition of the incubation medium. However, there is a genus-
specific mechanism promoting initial interaction of Chlamydia with eukaryotic cell 
membrane. Protein disulfide isomerase (PDI) is believed to play an essential role in the 
internalization mechanism utilized by multiple chlamydial species and serovars (Conant & 
Stephens , 2007). Nevertheless, the initial attachment of chlamydial particles to the host cell 
membrane leads to the recruitment of actin cytoskeleton to the attachment locus, formation 
of actin-rich tubular structures at the base of the attachment site, membrane invagination 
and final internalization of the bacteria (Clifton et al., 2004). Once internalized and 
incorporated into a non-acidified lysosome-free vacuole, termed an inclusion body, EB 
within begin to transform into metabolically active RB which are capable of dividing by 
binary fission (Hammerschlag, 2002) . The metabolic phenotype of RB characterized by 
active RNA and protein synthesis becomes established within 6-8 hours of the postinfection 
period and continues for the next 24-48 hours until reverse transformation to EB driven by 
unknown developmental stimuli takes place (Scidmore et al., 2003). The classic 
developmental cycle of chlamydial species terminates with membrane rupture and the 
release of newly synthesized EB initiating a new round of infection in the host cells.  
4. Dissemination  
Mucosal epithelial cells are a primary target for all major chlamydial biovars. Once 
inoculated to susceptible mucosa, chlamydial species accomplish their infectious cycle in the 
epitheliocytes, rupture their apical surface and spread canalicularly to the adjacent cells 
(Perry & Hughes, 1999). Canalicular spread of Chlamydia was traditionally attributed to the 
cases of C. trachomatis infection complicated by endometritis and salpingitis (Guaschino & 
De Seta, 2000). However similar horizontal spread of C. pneumoniae and C. psittaci within the 
epithelium leading to appearance of chlamydial EB and inflammatory cells in the alveolar 
lumen takes place in the lungs (Gieffers et al., 2004; Theegarten et al., 2008). This initial stage 
of chlamydial infection provides a short window of opportunity when the mechanism of 
local innate immunity may terminate developing infection due to continuous exposure of 
the pathogen to numerous antibacterial constituents of the epithelial secretion fluid (Perry & 
Hughes, 1999; Jayarapu et al., 2009) . Infected epithelial cells have been shown to secrete 
pro-inflammatory cytokines (INF-γ, TNF-α, interleukin 1 and 6, granulocyte-macrophage 
colony-stimulating factor) promoting cell migration to the infection site (Roan & Starnbach, 
2008). It is important that epitheliocyte-derived cytokines, rather than T-lymphocyte 
mediators, are believed to trigger tissue fibrosis and scarring in urogenital chlamydiosis 
(Derbigny et al., 2005). Regardless of the type of epithelium, granulocytes and macrophages 
are the first cells to migrate to the site of primary microbial insult. Both cell types can harbor 
www.intechopen.com
 
Chlamydia, Hepatocytes and Liver 
 
187 
viable chlamydial pathogens (Rupp et al., 2009; Chong-Cerrillo et al., 2003; Buendia et al., 
1999). Although granulocytes do not re-enter the systemic circulation (Yamagata et al., 2007) 
they can pass on viable Chlamydia to the macrophages whose ability to migrate through 
mucosal epithelium is a well established fact (Gieffers et al., 2004; Yamagata et al., 2007). 
Moreover, granulocytes are responsible for initiation of long-term immune response to 
chlamydial pathogens. Their systemic depletion ameliorates migration of CD4+ and CD8+ T 
cells to conjunctivae infected with C. trachomatis (Lacy et al., 2011).  
Chlamydial pathogens do not remain confined to the primary locus of infection. 
Identification of chlamydial pathogens in different organs and tissues reveals the obvious 
involvement of haemotogenic and lymphatic pathways in the generalization of chlamydial 
infection. The cell-mediated hypothesis for C. pneumoniae dissemination proposed by 
Gieffers  and others in 2004, has remained unchallenged so far and acquired further 
confirmation. It has been proposed that alveolar macrophages infected by granulocytes can 
penetrate mucosal barriers and gain access to the systemic circulation via lymphatic efferent 
flow as peripheral blood mononuclear cells with further spread to the endothelium, internal 
organs and tissues (Gieffers et al., 2004; Blasi et al., 2004) . A crucial piece of supporting 
evidence comes from reports describing the detection of chlamydial biovars in the regional 
lymph nodes and peripheral blood (Buxton et al., 1996; Sessa et al., 2007; Castro et al., 2010).  
There is ongoing discussion related to bacteremia and its role in dissemination of 
chlamydial infection. It is believed (Gieffers et al., 2004) that there is a low probability of free 
and sustained circulation of chlamydial EB in the bloodstream since chlamydial particles are 
likely to be the subject of rapid clearance by elements of the reticuloendothelial system. 
Furthermore, multiple surface-located adhesins, represented by the family of polymorphic 
membrane proteins (Molleken et al., 2010), are known to promote the adherence of 
chlamydial biovars to the endothelial cell and lymphocytes . However, according to our 
recently published results, EB of C. pneumoniae are identifiable by both electron microscopy 
and RT-PCR in serum specimens obtained from the patients with acute coronary syndrome 
(Petyaev et al., 2010). By a conservative estimate, our finding may be attributed to the partial 
lysis of blood cells during serum isolation. On the other hand, there is a certain possibility 
that free circulation of chlamydial pathogens in blood may take place in vivo under some 
pathophysiological conditions and/or stages of chlamydial disease.  
Although bacteremia becomes an indisputable pathophysiological feature of chlamydial 
infection, determination of chlamydial pathogens in the blood of patients by nucleic acid 
amplification protocol and/or bacterial culture has not yet become part of the algorithm in 
the laboratory diagnostics of chlamydiosis. This can be explained by some clinical cases 
where negative blood culture and PCR readings are observed in seropositive patients with 
obvious clinical signs of generalized chlamydial infection (Lamas & Eykyn 2009). The 
unknown prognostic value of the blood tests for chlamydial pathogens creates another 
issue. Further investigation is required to clarify the significance of bacteremia in the clinical 
manifestations and outcomes of chlamydiosis.  
Alternatively, the lymphatic pathway of generalization may represent a self-sufficient 
mechanism for sustaining dissemination of chlamydial pathogens in the human body. As an 
example, the nasal lymphatic system alone may provide a direct route for dissemination of 
bacterial pathogens colonizing the nasopharyngeal mucosa to the subarachnoid space 






trachomatis infection can be explained by direct connections between the pelvic lymphatic 
network and hepatic tissue (Park et al., 2008). 
There is an unresolved controversy about the role of chlamydial pathogens in neurological 
disorders. Although ultimate proof of the association between chlamydial infection and 
neurological disease has not presented yet, there are multiple reports on the identification of 
chlamydial species in brain specimens (Piercy et al., 1999; Beagley et al., 2009; Hammond et 
al., 2010). Along with direct lymphogenic dissemination mentioned above, monocyte-
mediated translocation through the blood/brain barrier is claimed to be a key mechanism 
for brain entry of chlamydial pathogens (Contini et al., 2010). On the other hand, 
cerebrospinal fluid may promote spread of chlamydial pathogens within brain structures 
(Contini et al., 2008). Whether chlamydial pathogens circulate in cerebrospinal fluid in free 
form or require macro-microphages  as the vehicle for transport inside the central nervous 
system remains under investigation . Although axonal transport plays a definite role in the 
spread of some infectious agents (Kalinke et al., 2011), there is no evidence that axonal 
delivery is any way involved in the dissemination of chlamydial infection in the nervous 
system. Reports on rare cases of sepsis induced by C. pneumoniae (Bustamante et al., 2002), C. 
psittaci (Janssen et al., 2006) and C. trachomatis (Kaan et al., 2002) require thorough 
evaluation and further conformation.  
5. Liver involvement: Clinical evidence 
Fitz-Hugh-Curtis syndrome is a complication of inflammatory pelvic disease involving 
inflammation of the hepatic capsule (perihepatitis) in patients infected with C. trachomatis 
and/or N. gonorrhoeae. From a clinical point of view, Fitz-Hugh-Curtis syndrome mimics 
the basic clinical features of acute cholecystitis and affects almost exclusively young 
women. This medical condition was initially observed by Carlos Stajano in 1920 who 
noticed formation of adhesion between Glisson’s liver capsule and the anterior abdominal 
wall in patients with venereal infection complaining of abdominal pain in the right upper 
quadrant (Stajano, 1920). Thomas Fitz-Hugh and Arthur Curtis gave a detailed 
description of the syndrome in the 1930s, establishing causative relation between “violin-
string” adhesions on the liver capsule, inflammatory pelvic disease and gonococcal 
infection (Curtis, 1930; Fitz-Hugh, 1934). It was not until the late 1970s, however, that C. 
trachomatis was linked to the etiology of Fitz-Hugh-Curtis syndrome (Wang et al., 1980). 
Presence of C. trachomatis in urogenital specimens, confirmed by PCR assay, is seen in up 
to 87% of patients with Fitz-Hugh-Curtis syndrome (Yang et al., 2008). According to 
modern understanding, clinical manifestations of the syndrome arise from the direct 
colonization of the liver capsule by C. trachomatis . Canalicular spread of the pathogen in 
peritoneal fluid via the right paracolic gutter as well as lymphogenic and hematogenous 
dissemination are believed to be implicated in the pathogenesis of perihepatitis (Peter et 
al., 2004). Despite the long-lasting belief that Fitz-Hugh-Curtis syndrome is exclusively 
attributed to inflammation within the hepatic capsule, perihepatic space and diaphragm, 
there is some evidence that the liver parenchyma, especially subcapsular regions of the 
liver, are involved in the course of disease (Lee et al., 2008). Subcapsular enhancement of 
the liver parenchyma and mildly elevated liver function tests in Fitz-Hugh-Curtis patients 
have been reported by many researchers (Kim et al., 2007; Lee et al., 2008) . These 
abnormalities are correctable with antibiotic treatment suggesting their direct association 
with infection. Moreover, C. trachomatis is reportedly isolated not only from the liver 
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capsule of patients (Wolner-Hansen et al., 1982), but also from hepatic parenchyma 
obtained by biopsy (Dan et al., 1987).  
To date there is neither an independent nosologic entity nor liver disease attributable 
specifically to C. pneumoniae. However, there are some reports on C. pneumoniae 
identification in human liver. The pathogen was identified in hepatocytes and sinusoidal 
cells of the periportal zone in a significant number of patients with acute liver allograft 
rejection (Lotz et al., 2004). A high occurrence rate of  C. pneumoniae  is also reported in both 
the explanted livers and hepatic biopsies of patients with primary biliary cirrhosis  
(Abdulkarim et al., 2004) . Although causative association between C. pneumoniae infection 
and primary biliary cirrhosis has been disputed by other researchers (Taylor-Robinson et al., 
2005) there have been new attempts to link some other hepatobiliary diseases (acute 
intrahepatic cholestasis, nonalcoholic steatohepatitis) to persistent C. pneumoniae infection 
(Bolukbas  et al., 2005; Bogdanos & Vergani, 2009). 
In contrast, there is a relatively extensive body of scientific literature suggesting that 
identification of C. psittaci in the internal organs   is quite a common phenomenon in cases of 
avian chlamydiosis. Recent advances in the molecular diagnostics of infection in birds have 
allowed routine detection of C. psittaci markers in different tissues, including liver 
(Nordentoft et al., 2011). The pathogen was identified by using PCR and 
immunohistochemistry protocols in the livers of budgerigars (Perpinan et al., 2010), canaries 
(Ferreri et al., 2007) and Amazon parrots (Raso et al., 2004). It has also been isolated from the 
livers of laying hens (Jizhang et al., 2010). A crucial piece of evidence comes from the 
analysis of human cases of C. psittaci infection. It is widely reported that the clinical 
manifestation of psittacosis is often associated with abnormal liver function in the patients 
(Ciftci et al., 2008; Maegawa et al., 2001., Goupil et al., 1998).  
6. Hepatotropism  
The tissue distribution of chlamydial pathogens has been extensively studied by many 
researchers using different routes of administration, dosage, strain virulence and type of 
experimental animals. Irrespective of these variables, the liver was a major site for 
clearance of C . trachomatis (Tuffrey et al., 1984), C. pneumoniae (Saikku et al.,1998) and C. 
psittaci (Iversen et al., 1976). Cell-mediated retention of the pathogens has also been seen 
in the spleen, bone morrow and lungs with the appearance of infected immune cells in 
their structure.  
The liver is one of the largest organs of the human body receiving about a quarter of cardiac 
output and releasing half of the lymph flow into the thoracic lymphatic duct (Bertolino et al., 
2002) . This unique positioning results in the constant exposure of liver cells to different 
foreign agents such as bacteria, viruses and parasites as well as immune cells infected with 
them. Very little is known about how and why chlamydial pathogens enter the liver tissue. 
In order to enter hepatocytes, chlamydial particles have first to depart from the site of 
primary colonization and navigate through the systemic circulation in cell-associated 
(neutrophils, monocytes and lymphocytes) or free form. It is believed that “sense of 
direction” in the migrating cells is driven by coordinated expression of cytokines and cell 
adhesion molecules on the surface of endothelium in the tissues and organs. Indeed, it has 






chlamydial infection is somehow controlled by Th1-type immune mediators, interleukin 12 
(IL-12) and interferon–γ (IFN-γ). In particular, mice genetically deficient in IL-12, IFN-γ or 
IFN-γ receptor-1 showed 100% mortality and markedly enhanced liver dissemination of C. 
muridarum after intranasal challenge with the pathogen. This observation is well supported 
by previously published results. A similar finding has been reported with anti-IFN-γ 
monoclonal antibody treatment in mice infected with C. psittaci (McCafferty et al., 1994) . 
Moreover, liver has been recently shown to express in a constitutive manner Intercellular 
Adhesion Molecule-1 (ICAM-1), a protein facilitating leukocyte endothelial transmigration, 
whose participation in dissemination of chlamydial pathogens has been recently discussed 
(Ochietti et al., 2002).  
Once chemotactic stimuli are recognized, bacterial pathogens in cell-associated form, enter 
the liver via highly fenestrated sinusoid capillaries, which are composed of sinusoidal lining 
cells - endothelial cells, macrophages and Kupffer cells (Celton-Morizur & Desdouets, 2010). 
In their concert action these cells implement clearance of bacteria, endotoxins and microbial 
debris from the bloodstream and regulate intra-sinusoidal cell migration (Gregory et al., 
2002). Kupffer cells are known to ingest and destroy adherent granulocytes containing 
infectious pathogens (Holub et al., 2009). In this regard, it becomes extremely important that 
Kupffer cells are shown to support chlamydial growth resulting in productive C. pneumoniae 
infection under “in vitro” and “in vivo” conditions (Marangoni et al., 2006). Kupffer cells can 
migrate to Disse’s space and establish direct contact with hepatocytes through their 
cytoplasmic extensions delivering some internal constituents (pro-inflammatory cytokines, 
mediators etc) to the liver   trabeculae (Perrault & Pecheur, 2009). In this setting, initial 
attachment of Chlamydia-infected granulocytes to Kupffer cells with further propagation of 
chlamydial pathogens in Kupffer cells and their final transmission to the hepatic 
microenvironment becomes a conceivable chain of events explaining the appearance of 
chlamydial pathogens in the liver.  
It is worth noting that some other infectious pathogens use a similar strategy to invade 
hepatocytes. As an example, hepatitis B virus is revealed to invade liver tissue by 
scavenging liver sinusoidal endothelial cells, rather than hepatocytes themselves (Breiner et 
al., 2001). Therefore, initial invasion of non-hepatic cells might be a general mechanism in 
the development of hepatocyte infection. 
Hepatocytes are polarized epithelial cells with basolateral and apical poles facing blood or 
bile respectively. The integrity of hepatic trabeculae and separation of blood and bile flows 
are maintained by tight junctions among adjacent hepatocytes. The basolateral surface of 
hepatocytes is considered to be a major gate for infectious pathogens delivered to the liver 
with the blood flow (Perrault & Pecheur, 2009). General mechanisms underlying chlamydial 
entry in hepatocytes are very likely to resemble those seen in other epithelial cells. 
Hepatocytes express most of the receptors required for chlamydial attachment and entry 
into the eukaryotic host cell. Liver has a remarkably high expression level for insulin-like 
growth factor 2, estrogen receptor complex and platelet-derived growth factor receptor 
required for chlamydial entry (Leung et al., 2004) . Moreover, liver is known to express 
abundantly LDL-receptor (Dietschy & Turley, 2002), which can be implemented in our view 
in the pathogenesis of chlamydiosis. Using an immunoprecipitation approach we have 
found (Petyaev et al., 2010) that two chlamydial biovars – C. trachomatis and C. pneumoniae 
can bind ApoB-containing lipoproteins under “in vitro” conditions. This was strikingly 
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distinct from no interaction with the HDL fraction. Furthermore, preincubation of the 
chlamydial pathogens with LDL particles enhanced in our experiments their ability to infect 
an immortalized hepatic HepG2 cell line, known to express abundantly LDL receptor. 
Association of bacterial particles with plasma lipoproteins and subsequent receptor-
facilitated uptake does not seem to be an absolute requirement for chlamydial entry since it 
is possible to establish productive chlamydial infection under serum-free conditions . 
However, LDL- receptor appears to play an as yet poorly understood role in the initial 
stages of chlamydial infection. The likelihood of the Chlamydia-lipoprotein interactions 
under  in vivo conditions becomes even more clear due to our recent identification  of cross-
reactive antibodies  against chlamydial lipopolysaccharide  and human ApoB (Petyaev et al., 
2011). Besides adding a new variant to the physico-chemical aspect of interaction between 
Chlamydia and lipoproteins, the cross-protective immunological response and subsequent 
emergence of lipoprotein–specific antibodies may have a detrimental impact on the vascular 
endothelium. LDL-containing immune complexes are known to be taken up by lipid-laden 
macrophages and extensively deposited in atherosclerotic plaque (Miller et al., 2010). 
Therefore association of immune complexes with Chlamydia encouraged with cross-reactive 
antibody will endorse the pathogen delivery into atherosclerotic plaque.  
It is worth mentioning that other infectious pathogens utilize lipoproteins and lipoprotein 
receptors in mechanisms of infectivity. It is well known that hepatitis C virus particles in 
human plasma are bound to very low density lipoproteins (VLDL) and low density 
lipoproteins (LDL) forming “viral lipoparticles” (Andre et al., 2005) .  Their attachment and 
entry into hepatocytes requires LDL-receptor and surface receptor CD81 providing a dual 
receptor mechanism for viral attachment and entry into the target cells (Bartosch et al., 
2003). Therefore, the ability of some infectious agents to invade hepatocytes seems to exploit 
the mechanism of molecular mimicry when an infectious particle “hijacks” a eukaryotic 
ligand and utilizes the corresponding eukaryotic membrane receptor as well as cross-
reactive immunity for invasion of the host cell. 
7. Hepatocytes 
Extensive in vitro studies using cultured hepatocytes are required to understand the 
molecular mechanisms of liver involvement in chlamydial disease and its outcomes. A 
major methodological problem emerges from the fact that hepatocytes lose their tissue-
specific phenotype and expression of liver-specific genes within 24-48 hours of isolation. For 
this reason immortalized hepatic cell lines have only a remote resemblance to the metabolic 
phenotype of whole liver (Guillouzo & Guguen-Guillouzo, 2008). This difficulty can be 
partially overcome by the use of freshly isolated hepatocytes plated onto collagen-coated 
dishes in the presence of certain hormones (Shimomura et al., 1999). It has been shown 
during the last few years that major chlamydial species can efficiently propagate in cultured 
hepatoma cells (Wang et al., 2007; Bashmakov et al., 2010) and accomplish their entire 
developmental cycle with the final release of infective progeny from ruptured hepatocytes. 
A similar observation has been made in experiments with freshly isolated hepatocytes from 
rat liver (I.M. Petyaev et al, 2011, unpublished results). Nevertheless, the nature of the 
multifaceted relationship emerging between Chlamydia and hepatocytes during infection can 
be understood only in the context of the unique properties of chlamydial pathogens as 






The chlamydial genome is relatively conserved. Among 1009 genes of C. caviae (formerly C. 
psittaci), 798 have orthologs present in C. pneumoniae and C. trachomatis (Read et al., 2003). 
These genes supposedly embody a nominal set of genetic material required for the survival 
of chlamydial species in host cells. The chlamydial genome contains genes encoding 
complete glycogen turnover, aerobic respiration and various transporter systems. However, 
genes responsible for biosynthesis of purine/pyrimidine bases, lipids and amino acids are 
absent or poorly represented (Vandahl et al., 2004). Moreover, the C. trachomatis genome 
encodes some genes for de novo synthesis of fatty acids, phosphatidylethanolamine and 
phosphatidylglycerol, although genes involved in polyunsaturated fatty acid pathways, 
biosynthesis of cholesterol, sphingolipids and glycerophospholipids have not been 
identified (Stephens et al., 1998) . Therefore chlamydial inclusions have to acquire major 
lipids such as cholesterol, sphingomyelin, and neutral lipids from the host cells by 
intercepting Golgi-derived lipid-containing vesicles (Moore et al., 2008) . Chlamydial 
pathogens are obligate parasites completely relying on the host cell metabolism. Nutrient 
deficiency in the host cells is not a matter of “discomfort” for replicating chlamydial 
pathogens it is rather a matter of ultimate survival and their ability to propagate. As an 
example, C. trachomatis is unable to replicate in the Chinese hamster ovary-derived cell line 
SPB-1, a mutant cell line deficient in sphingolipid biosynthesis (van Ooij et al., 2000). 
Similarly, severe tryptophan deficiency in the host cells leads to early developmental arrest 
of C. trachomatis and other chlamydial pathogens (Leonhardt et al., 2007). The metabolic 
profile of host cells predetermines the efficiency of chlamydial growth. It is believed, that 
endothelial cells provide a better metabolic environment for C. pneumoniae than monocytes 
due to distinct differences in iron homeostasis (Bellmann-Weiler et al., 2010).  
If availability of substrates were the single requirement for sustaining chlamydial infection 
in eukaryotic cells, hepatocytes would certainly be a most advantageous type of host cell for 
chlamydial pathogens. Hepatocytes contain an enormous variety of compounds essential for 
Chlamydia . Liver is the organ with the highest rate of 3-hydroxy-3-methyl-glutaryl-CoA 
(HMG-CoA) reductase expression, a rate limiting enzyme of cholesterol biosynthesis 
(Dietschy & Turley, 2002). Hepatic cells also synthesize and store various fatty acids, 
triglycerides and phospholipids. They also operate a highly sophisticated system for 
endoplasmic vesicular transport of lipids (Jump, 2011). In addition, liver is the central organ 
of tryptophan turnover (Brandacher et al., 2007) with a remarkable ability to synthesize and 
catabolize different amino acids .  
Recent studies demonstrate that chlamydial pathogens affect hepatocyte-specific functions. 
C. trachomatis infection in hepatocytes has been shown to be accompanied by enhanced 
transcription of fatty acid binding protein (FABP) leading to increased fatty acid uptake, 
while overexpression of FABP promotes chlamydial growth in transfected hepatocytes  
(Wang et al., 2007) . C. trachomatis infection also impairs endogenous transcription of 
another crucial gene of lipid homeostasis – LDL-receptor (LDL-R). We found that the 
decline in LDL-R mRNA in HepG2 hepatoma cells reflects multiplicity of infection and can 
be reversed by treatment with mevastatin, an inhibitor of HMG-CoA reductase. A similar 
tendency has been observed in HepG2 cells infected with C. pneumoniae (Y.Bashmakov et al, 
2010 unpublished results). In both cases mevastatin treatment also reduced infection rate in 
cultured cells . First of all these results are in good agreement with the anti-chlamydial 
effects of statins reported in animal studies (Erkkaila et al., 2005; Tiirola et al., 2007). 
Secondly, the anti-chlamydial effects of statins observed under in vivo and in vitro conditions 
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open a new perspective in treatment of chlamydiosis whose “signature feature” is drug-
resistance of the intracellular bacterial pathogen. Unlike other anti-microbial agents, statins 
have recently been shown to mediate their effects on infection by inhibiting post-
translational protein prenylation in both host cell and infectious agent in a manner 
independent of cholesterol depletion (Khan et al., 2009; Amet et al., 2008). At the same time, 
protein prenylation is  vital for Chlamydia and the functioning of the chlamydial Rab protein 
family represented by almost 70 members . Silencing of Rab 6 and Rab 11 by siRNA inhibits 
replication of C. trachomatis and impairs lipid acquisition from the host cells (Capmany et al., 
2010). Extensive studies are required to show if targeting the geranylgeranylation system 
does indeed hold promise in the treatment of persistent chlamydial infection. 
8. Conclusions 
To the best of our knowledge, this chapter represents the very first attempt to discuss the 
small but growing body of evidence suggesting liver involvement in chlamydiosis. The 
variety of extragenital and extraocular manifestations of C. trachomatis infection as well as 
the frequent appearance of C. pneumoniae and C. psittaci in extra-respiratory tissues suggest 
the systemic character of chlamydial disease and validate a systemic therapeutic approach 
to the treatment of chlamydiosis. However, conventional diagnostic interventions in modern 
hepatology impose a substantial limit on direct assessment of chlamydial pathogens in the 
liver. Nevertheless, presence of chlamydial pathogens in the liver tissue can be verified in a 
considerable number of patients in particular those with inflammatory hepatobiliary 
disease. According to our recent results, genomic and immunohistochemical markers of C. 
pneumoniae are identifiable in the liver biopsies of 10.2% of patients with calculous 
cholecystitis, whereas C. trachomatis markers were found in 20.5% of patients from the same 
category (I.M. Petyaev et al, 2011, unpublished results). It has yet to be addressed whether 
the identification of chlamydial markers in the liver has any pathophysiological significance 
and possible relation to the course of disease or viability of the bacteria. Thorough 
bacteriological analysis of liver isolates, their susceptibility to antibiotics and their ability to 
cause aberrant and persistent variants of infection need to be studied .  
To date, liver involvement in chlamydiosis constitutes a subject of rare and often casuistic 
communications overshadowed by reports on association of chlamydial infection with 
atherosclerosis and other inflammatory diseases . However, the apparent hepatotropism of 
chlamydial pathogens creates in our opinion a missing link between chlamydial infection 
and vascular disease since the liver plays an indispensable role in both lipid homeostasis 
and systemic inflammatory response. LDL receptor-mediated hepatic clearance of pro-
atherogenic lipoproteins is a main route for cholesterol disposal in the human body. 
Therefore, the negative effect of chlamydial pathogens on LDL receptor expression in 
cultured hepatocytes may constitute an extremely important mechanism in explaining 
abnormalities of plasma lipid profile in the patient with chlamydiosis . It remains to be 
answered in future if the presence of chlamydial pathogens in liver or hepatocytes has any 
impact respectively on hepatic clearance or uptake of plasma lipoproteins via the LDL 
receptor-mediated mechanism.  
Special consideration should be given to the evaluation of the possible clinical significance 
of interaction between chlamydial biovars with ApoB-containing lipoproteins. It is 






chlamydial pathogens, in particular C. pneumoniae, to host cell with high or moderate 
expression of LDL-receptor. Finally, a question as to what extent chlamydial pathogen 
propagation in liver may affect systemic inflammatory response and hepatic insulin 
sensitivity has to be explored in the future.  
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